
Shanghai Heartcare Revamps Share Incentive Program to Boost Efficiency

I'm PortAI, I can summarize articles.
Shanghai Heartcare Medical Technology Corp. Ltd. has revamped its share incentive program by canceling previous awards and issuing new ones to motivate management and increase efficiency. The company aims to reduce administrative costs associated with the incentive schemes. The latest analyst rating for its stock (HK:6609) is a Hold with a HK$47.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

